Improving smoking cessation support for people living with HIV

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a proactive model of provider contact to deliver smoking cessation support for individuals living with HIV, comparing it to standard care. Participants will be randomly assigned to receive either Treatment As Usual (TAU) or the Proactive Outreach with Medication Opt-out for Tobacco Treatment Engagement (PrOMOTE). The primary goal is to assess the effectiveness of these approaches in increasing smoking cessation rates and quit attempts at a 12-week follow-up. Additionally, the study will explore barriers and facilitators to implementing the PrOMOTE model and its impact on health outcomes related to HIV.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 21 and older
* Current diagnosis of HIV
* Current smoker (defined as self-report of current smoking)
* Willing to be randomized
* English speaking

Exclusion Criteria:

* Currently taking part in any other tobacco treatment program or using cessation medication (i.e., taking nicotine replacement therapy or other cessation medications, enrolled in the Quitline, or in another study)
* Currently imprisoned
* Pregnant women
* Non-English speaking persons

Where it's running

• Medical University of South Carolina
  Charleston, South Carolina, United States Recruiting

Study contacts

• Study coordinator: Chloe Morone
• Email: morone@musc.edu
• Phone: 843-637-0734

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Semaglutide to reduce drinking, smoking, and heart disease risk in people with HIV

  This trial tests whether the diabetes drug semaglutide can help adults living with HIV drink less alcohol, smoke fewer cigarettes, and lower their heart disease risk.

  Recruiting Phase 2 Vanderbilt University Medical Center · Nashville, Tennessee · NCT07221214

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.